A Naloxone kit. The Canadian Press
Health Canada has issued a warning about errors in the instructions included with some take-home naloxone kits. The affected kits, produced by Canadian Hospital Specialties Ltd., have incorrect guidance on how to use naloxone, which could affect its effectiveness in treating opioid overdoses.
Naloxone is a crucial medication used to reverse the effects of an opioid overdose. It can be administered either as a nasal spray or an injection and is available without a prescription. The medication works by temporarily restoring breathing in someone who has overdosed on opioids.
However, Health Canada has discovered that the "SAVE ME" instructional cards included in these kits may have faulty information regarding dosage timing. According to the correct guidelines, if necessary, a second dose of naloxone can be given two to three minutes after the first dose. Unfortunately, the instructions in the affected kits incorrectly suggest waiting three to five minutes before administering a second dose.
This discrepancy could lead to delays in providing necessary treatment during an overdose emergency, potentially compromising the effectiveness of the naloxone. Health Canada is advising anyone who has one of these kits to seek out the correct instructions to ensure they are prepared to respond effectively in an emergency.
If you have a kit with the incorrect instructions, you should contact Canadian Hospital Specialties Ltd. by email at recalls@chsltd.com, or get in touch with the store where you purchased the kit. They can provide you with a corrected "SAVE ME" card with accurate information.
This alert affects both the nasal spray and injectable forms of naloxone kits. Health Canada is urging all users to double-check their kits and ensure they have the correct instructions to help save lives in the event of an opioid overdose.
